Educational information, not medical advice — ask your doctor or midwife.
Microcurrent therapy uses electrical current in the microamp range — roughly a thousandth of the current used in a standard TENS machine. Because the current is so small, most people feel nothing at all, or only a faint tingle. It is delivered either through sticky electrode pads placed on either side of the treated area, or with handheld metal probes moved over the skin, or in cosmetic use with a small wand rolled across the face.
The idea behind it is that the body's own cells operate with tiny electrical gradients, and that injured or inflamed tissue has a measurably different electrical resistance. Supplying current in a similar range is proposed to nudge cell membrane transport, ATP production and repair signalling rather than to block nerve signals the way stronger electrical stimulation does. That is a plausible mechanism with laboratory support, but the leap from cell cultures to a person's shoulder pain is much longer than most marketing admits.
In practice microcurrent lives in two quite separate worlds. In physiotherapy, sports medicine and wound care it is a minor adjunct with a small, mixed body of trials. In the beauty industry it is sold as a "non-surgical facelift", where the claims are far stronger than the published evidence. It is not part of any traditional medical system; it is a modern device therapy.
Proposed mechanisms are drawn largely from cell and animal work: microamp current appears to increase ATP synthesis and protein transport in fibroblasts, influence the migration of repair cells along an electrical gradient (galvanotaxis), and modulate local inflammatory mediators and oedema. In wound care, applying current across a wound is thought to restore the natural 'current of injury' that skin generates when broken. For pain, effects may involve reduced local inflammation and altered nociceptive signalling rather than the gate-control nerve blocking that TENS relies on — which is why relief, when reported, tends to build over hours rather than switching on instantly. In cosmetic use, current in this range can cause low-grade contraction of facial muscles and transiently increase local circulation, producing a short-lived tightening effect. None of these mechanisms has been convincingly confirmed as the driver of clinical benefit in humans.
Clinic units allow the practitioner to set current (commonly 20–600 microamps), frequency and polarity, and deliver through pads or probes for 20–60 minutes. Frequency-specific microcurrent (FSM) uses paired frequencies said to target specific tissues and conditions; the frequency lists come from early 20th-century practitioner notebooks and have no independent validation. Home pain devices are lower-powered and simpler. Facial microcurrent wands, both salon and home models, run at very low output and are used for 5–20 minutes on gel-covered skin several times a week. Output quality varies enormously between devices, and cheap units may deliver far less current than claimed — one reason results are so inconsistent.
Electricity has been applied to the body medically since the 1700s, but microcurrent as a distinct practice dates to the 1970s and 1980s, when researchers including Robert O. Becker studied the electrical properties of injured and regenerating tissue and Ngok Cheng's laboratory work suggested that microamp current increased ATP production in skin while higher currents reduced it. Devices marketed as MENS units followed in sports clinics. Frequency-specific microcurrent was popularised in the 1990s by Carolyn McMakin, based on a list of frequencies attributed to an osteopathic practitioner from the 1920s. Cosmetic microcurrent grew separately out of the facial-toning device market from the 1980s and is now the largest commercial use by far.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.